Markets

Amedisys (AMED) Worth Watching: Stock Moves 8.4% Higher

Amedisys Inc.AMED was a big mover last session with its shares rising over 8% on the day. The upside was owing to the company's announcement of strong financial results for the third quarter and nine months ended Sep 30, 2015. Net income, EBITDA and revenues grew on a year-over-year basis. This development led to far more shares changing hands yesterday than in a normal session. This breaks the recent trend of the company as the stock is now trading above the past month's volatile price range of $35.27 to $40.91.

This leading home health and hospice company has seen one positive estimate revision over the past 30 days. The Zacks Consensus Estimate has also moved higher over the same period. This implies solid trading potential for the company. So make sure to keep an eye on this stock going forward to see if yesterday's rally can turn into more strength down the road.

Amedisys currently has a Zacks Rank #3 (Hold).

Investors interested in the home health care industry may consider Chemed Corp. CHE which carries a Zacks Rank #2 (Buy).

Is AMED going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

AMEDISYS INC (AMED): Free Stock Analysis Report

CHEMED CORP (CHE): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

AMEDCHE

Other Topics

Investing Stocks

Latest Markets Videos

Zacks

Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

Learn More